Ultragenyx Pharmaceutical Inc. buy JPMorgan Chase & Co.
Start price
12.03.26
/
50%
€19.10
Target price
12.03.27
€64.16
Performance (%)
5.92%
Price
09.04.26
€20.40
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ shows slight gains of 5.92%. This prediction currently runs until 12.03.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Ultragenyx Pharmaceutical Inc. | 1.554% |
| iShares Core DAX® | 3.075% |
| iShares Nasdaq 100 | 2.876% |
| iShares Nikkei 225® | 5.981% |
| iShares S&P 500 | 2.231% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (RARE) had its price target lowered by JPMorgan Chase & Co. from $120.00 to $74.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€36.00
27.03.25
27.03.25
€108.68
27.03.26
27.03.26
-53.33%
28.03.26
28.03.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€44.00
21.11.24
21.11.24
€96.83
21.11.25
21.11.25
-34.09%
22.11.25
22.11.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€49.60
27.02.24
27.02.24
€81.12
27.02.25
27.02.25
-17.74%
28.02.25
28.02.25